Inefficacy of Immunosuppressive Therapy for Severe Aplastic Anemia Progressing From Non-SAA: Improved Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

BACKGROUND AND AIMS: This study aimed at comparing the efficacy and safety of severe aplastic anemia (SAA) cases that had met the criteria for SAA at the time of diagnosis (group A) with SAA that had progressed from non-SAA (NSAA) (group B), both undergoing first-line immunosuppressive therapy (IST)...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Limin, Zhao, Xin, Miao, Miao, Zhang, Yanming, Jiao, Wenjing, Lei, Meiqing, Zhou, Huifen, Wang, Qingyuan, Cai, Yifeng, Zhao, Liyun, Shangguan, Xiaohui, Liu, Zefa, Xu, Jinge, Zhang, Fengkui, Wu, Depei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490923/
https://www.ncbi.nlm.nih.gov/pubmed/34621679
http://dx.doi.org/10.3389/fonc.2021.739561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490923/
https://www.ncbi.nlm.nih.gov/pubmed/34621679
http://dx.doi.org/10.3389/fonc.2021.739561

Ejemplares similares